Verteporfin
Records for this ingredient, by country (identity only).
ATC S01LA01 · 10 markets · 12 records
US 2 records · 1 shown of 1
- 15 mg per mL / per unit basis not statedinjectionVisudyne
GB 2 records · 1 shown of 1
- 15 mg per mL / per unit basis not statedinjectionVisudyne 15mg powder for solution for infusion vialsManufacturer: Neon Healthcare Ltd
CA 1 records · 1 shown of 1
- 15 mgpowderVisudyne
SG 1 records · 1 shown of 1
- 15 mg/vial per mL / per unit basis not statedinjectionVISUDYNE FOR INJECTION 15 mg/vial
ES 1 records · 1 shown of 1
- 15 mg per mL / per unit basis not statedinjectionVisudyne
TW 1 records · 1 shown of 1
- 15 mg per mL / per unit basis not statedinjectionVISUDYNE POWDER FOR SOLUTION FOR INFUSION 15MG/VIAL維視達凍晶注射劑１５毫克
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 15 mg per mL / per unit basis not statedinjectionビスダイン静注用15mg
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 15 mg per mL / per unit basis not statedinjectionVISUDYNE 15 mg, poudre pour solution pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | SG | ES | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 mg per mL / per unit basis not stated cannot compare injection | Visudyne | Manufacturer: Neon Healthcare Ltd Visudyne 15mg powder for solution for infusion vials | Visudyne | VISUDYNE POWDER FOR SOLUTION FOR INFUSION 15MG/VIAL 維視達凍晶注射劑１５毫克 | ビスダイン静注用15mg | VISUDYNE 15 mg, poudre pour solution pour perfusion | ||||
| 15 mg/vial per mL / per unit basis not stated cannot compare injection | VISUDYNE FOR INJECTION 15 mg/vial | |||||||||
| 15 mg powder | Visudyne | |||||||||
unknown | VISUDYNE POWDER FOR INJECTION 15MG | Visudyne |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · SG · HK · EU and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG · HK · EU que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG · HK · EU 有记录（未在本表显示）。 另有 3 個規格/劑型僅在 CA · SG · HK · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.